Our people

Rebecca Brooks

Rebecca Brooks

Our People

Rebecca Brooks

Associate, Patent Attorney

Life Sciences


Our People

Our IP specialists work at all stages of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.

View the team

News & Insights

We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.

Learn more

Law & Practice Guide

We believe in making it easy for you to find the information that you want – and you can always contact us if you can’t find what you need

Read our law and practice guides

Rebecca has experience in all aspects of the patenting process, including original drafting, filing strategy and prosecution, which means that she is ideally placed to advise clients in these areas. 

She assists clients with oppositions and appeals at the EPO, with specific experience in opposing and defending patents covering antibody-based therapies. Rebecca also has a particular interest in assisting clients with due diligence and freedom-to-operate projects, with experience in a wide range of technologies. 

Rebecca’s highly technical background is in cell biology, and she has a keen interest in a broad range of other technical areas, including cell therapies, the microbiome, and plant biology. 

Areas of Expertise

  • Antibody technology (human and veterinary applications)
  • Cell therapy and immunotherapy
  • Cancer therapeutics and biomarkers
  • Microbiome
  • Cell culture
  • Stem cell technology
  • Diagnostics


Rebecca works with a range of organisations including multinational companies and start-ups. Her clients are based predominantly in Europe, Japan, the USA, and Singapore, providing a varied and global outlook in her work.


Rebecca has a BSc and PhD in Biochemistry from the University of Bristol. During her undergraduate degree, Rebecca spent 12 months at a pharmaceutical company where her research project focused on the use of quantitative PCR and animal models to assess disease progression. 

Following her PhD, Rebecca worked as a postdoctoral researcher at the University of North Carolina in the USA, where her research focused on cell migration during wound healing and cancer. She joined Mewburn Ellis LLP in 2021 and qualified as a European Patent Attorney in the same year. She also qualified as a Chartered Patent Attorney in 2022.